Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 69, Issue 6, Pages S57-S65Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2013.04.041
Keywords
carvedilol; ivermectin; medical therapy; permethrin; rosacea; subantimicrobial-dose doxycycline
Categories
Funding
- Galderma International
Ask authors/readers for more resources
Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available